Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Preliminary Outcomes of a Cross-Site Cognitive-Behavioral and Neuromuscular Integrative Training Intervention for Juvenile Fibromyalgia.

Tran ST, Guite JW, Pantaleao A, Pfeiffer M, Myer GD, Sil S, Thomas SM, Ting TV, Williams SE, Edelheit B, Ounpuu S, Rodriguez-MacClintic J, Zemel L, Zempsky W, Kashikar-Zuck S.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):413-420. doi: 10.1002/acr.22946.

PMID:
27331358
2.

A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis.

Weiss JE, Haines KA, Chalom EC, Li SC, Walco GA, Nyirenda TL, Edelheit B, Kimura Y.

Pediatr Rheumatol Online J. 2015 Aug 27;13:36. doi: 10.1186/s12969-015-0034-8.

3.

Cranial nerve VI palsy as an initial presentation of necrotizing sarcoid granulomatosis in a 14-year-old female: case report and literature review.

Doss M, Araneta R 3rd, Fiel-Gan M, Edelheit B.

Semin Arthritis Rheum. 2015 Feb;44(4):456-60. doi: 10.1016/j.semarthrit.2014.07.004. Epub 2014 Jul 17. Review.

PMID:
25130755
4.

Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2014 May;66(5):732-40. doi: 10.1002/acr.22212.

5.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

6.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

7.

Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.

Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, Curran M, Feldman BM, Gewanter H, Griffin T, Haines K, Hoeltzel MF, Isgro J, Kahn P, Lang B, Lawler P, Shaham B, Schmeling H, Scuccimarri R, Shishov M, Stringer E, Wohrley J, Ilowite NT, Wallace C; Juvenile Dermatomyositis Subcommittee of the Childhood Arthritis and Rheumatology Research Alliance.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):546-53. doi: 10.1002/acr.20695.

8.

Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Rheumatology (Oxford). 2010 Dec;49(12):2381-90. doi: 10.1093/rheumatology/keq277. Epub 2010 Aug 27.

9.
10.

Clinical trials for post-streptococcal reactive arthritis.

Lehman TJ, Edelheit BS.

Curr Rheumatol Rep. 2001 Oct;3(5):363-4. Review.

PMID:
11564365
11.

Systemic lupus erythematosus in a pediatric patient with congenital acquired immunodeficiency syndrome.

O'Keefe K, Edelheit B, Onel K, Tantawi M, Johann-Liang R.

Pediatr Infect Dis J. 2001 Apr;20(4):450-2.

PMID:
11332676

Supplemental Content

Loading ...
Support Center